Your browser doesn't support javascript.
loading
Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapy.
Kushner, Brian H; LaQuaglia, Michael P; Cardenas, Fiorella Iglesias; Basu, Ellen M; Gerstle, Justin T; Kramer, Kim; Roberts, Stephen S; Wolden, Suzanne L; Cheung, Nai-Kong V; Modak, Shakeel.
Affiliation
  • Kushner BH; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • LaQuaglia MP; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Cardenas FI; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Basu EM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Gerstle JT; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Kramer K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Roberts SS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Wolden SL; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Cheung NV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Modak S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Int J Cancer ; 153(12): 2019-2031, 2023 12 15.
Article in En | MEDLINE | ID: mdl-37602920

Full text: 1 Database: MEDLINE Main subject: Neoplasm Recurrence, Local / Neuroblastoma Type of study: Prognostic_studies Limits: Adolescent / Child / Humans / Infant Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Neoplasm Recurrence, Local / Neuroblastoma Type of study: Prognostic_studies Limits: Adolescent / Child / Humans / Infant Language: En Year: 2023 Type: Article